| MLEC | Moolec Science SA | 0.01 | -99.96% |
| LSB | LakeShore Biopharma Co Ltd | 0.02 | -99.91% |
| ENVB | Enveric Biosciences Inc | 0.08 | -99.68% |
| KPRX | Kiora Pharmaceuticals Inc | 0.14 | -99.42% |
| JAGX | Jaguar Health Inc | 0.30 | -98.77% |
| LITS | Lite Strategy Inc | 0.31 | -98.73% |
| HRTX | Heron Therapeutics Inc | 0.51 | -97.94% |
| AFMD | Affimed N.V. | 0.53 | -97.86% |
| FTRE | Fortrea Holdings Inc | 0.57 | -97.69% |
| BDRX | Biodexa Pharmaceuticals Plc | 0.58 | -97.67% |
| ENSC | Ensysce Biosciences Inc | 0.61 | -97.53% |
| CLSD | Clearside Biomedical, Inc. Common Stock | 0.64 | -97.39% |
| ONCT | Oncternal Therapeutics Inc | 0.72 | -97.08% |
| SRPT | Sarepta Therapeutics Inc | 0.73 | -97.03% |
| CELU | Celularity Inc - Class A | 0.85 | -96.57% |
| GOSS | Gossamer Bio Inc | 0.98 | -96.05% |
| XLO | Xilio Therapeutics Inc | 0.98 | -96.03% |
| SCNI | Scinai Immunotherapeutics Ltd | 1.00 | -95.97% |
| AGEN | Agenus Inc | 1.05 | -95.77% |
| QLGN | Qualigen Therapeutics, Inc. Common Stock | 1.12 | -95.47% |
| FBIOP | Fortress Biotech Inc | 1.25 | -94.95% |
| IMRN | Immuron Ltd | 1.30 | -94.74% |
| KPTI | Karyopharm Therapeutics Inc | 1.30 | -94.73% |
| BOLT | Bolt Biotherapeutics Inc | 1.31 | -94.70% |
| HCWB | HCW Biologics Inc | 1.31 | -94.68% |
| CSBR | Champions Oncology Inc | 1.39 | -94.38% |
| ADAP | Adaptimmune Therapeutics plc American Depositary Shares | 1.39 | -94.36% |
| MDXG | Mimedx Group Inc | 1.42 | -94.26% |
| RVNC | Revance Therapeutics Inc | 1.48 | -94.01% |
| FBIO | Fortress Biotech Inc | 1.51 | -93.87% |
| ONCO | Onconetix Inc | 1.54 | -93.78% |
| AVIR | Atea Pharmaceuticals Inc | 1.55 | -93.72% |
| PBYI | Puma Biotechnology Inc | 1.62 | -93.44% |
| MGNX | Macrogenics Inc | 1.62 | -93.43% |
| VNDA | Vanda Pharmaceuticals Inc | 1.69 | -93.16% |
| CRMD | CorMedix Inc | 1.70 | -93.14% |
| NEUP | Neuphoria Therapeutics Inc | 1.70 | -93.12% |
| GLPG | Galapagos NV | 1.74 | -92.96% |
| ADCT | Adc Therapeutics SA | 1.77 | -92.85% |
| VERU | Veru Inc | 1.79 | -92.76% |
| SVA | Sinovac Biotech Ltd | 1.83 | -92.59% |
| NERV | Minerva Neurosciences Inc | 1.87 | -92.44% |
| RIGL | Rigel Pharmaceuticals | 1.90 | -92.33% |
| PTN | Palatin Technologies Inc | 1.96 | -92.06% |
| THTX | Theratechnologies Inc | 1.98 | -91.97% |
| MGX | Metagenomi Inc | 2.07 | -91.61% |
| PLX | Protalix BioTherapeutics Inc | 2.09 | -91.55% |
| BDTX | Black Diamond Therapeutics Inc | 2.11 | -91.45% |
| NAGE | Niagen Bioscience Inc | 2.12 | -91.43% |
| XBIO | Xenetic Biosciences Inc | 2.21 | -91.04% |
| RADX | Radiopharm Theranostics Ltd | 2.22 | -91.02% |
| HRMY | Harmony Biosciences Holdings Inc | 2.28 | -90.76% |
| SPRC | SciSparc Ltd | 2.33 | -90.56% |
| PHAR | Pharming Group N.V. | 2.36 | -90.46% |
| NVAX | Novavax Inc | 2.39 | -90.32% |
| SPRO | Spero Therapeutics Inc | 2.42 | -90.20% |
| GNFT | GENFIT S.A. American Depositary Shares | 2.44 | -90.14% |
| CRIS | Curis Inc | 2.47 | -90.02% |
| SAVA | Cassava Sciences Inc. | 2.54 | -89.73% |
| CGEN | Compugen Ltd | 2.63 | -89.36% |
| FULC | Fulcrum Therapeutics Inc | 2.66 | -89.25% |
| VRCA | Verrica Pharmaceuticals Inc | 2.66 | -89.24% |
| HYFT | MindWalk Holdings Corp | 2.68 | -89.16% |
| CTXR | Citius Pharmaceuticals Inc | 2.69 | -89.09% |
| APVO | Aptevo Therapeutics Inc | 2.70 | -89.06% |
| SXTP | 60 Degrees Pharmaceuticals Inc | 2.79 | -88.71% |
| AAPG | Ascentage Pharma Group International | 2.86 | -88.42% |
| CDXS | Codexis Inc | 2.88 | -88.37% |
| REVB | Revelation Biosciences Inc | 2.88 | -88.34% |
| ICCC | Immucell Corp | 2.95 | -88.05% |
| SABS | SAB Biotherapeutics Inc | 2.96 | -88.03% |
| MNKD | Mannkind Corp | 3.06 | -87.63% |
| VALN | Valneva SE | 3.11 | -87.40% |
| BCAB | BioAtla Inc | 3.20 | -87.04% |
| ARDX | Ardelyx Inc | 3.23 | -86.91% |
| JAZZ | Jazz Pharmaceuticals plc | 3.24 | -86.87% |
| BGMS | Bio Green Med Solution Inc | 3.27 | -86.75% |
| DNA | Ginkgo Bioworks Holdings Inc - Class A | 3.32 | -86.56% |
| EVGN | Evogene Ltd | 3.32 | -86.55% |
| RARE | Ultragenyx Pharmaceutical Inc | 3.35 | -86.44% |
| ACAD | Acadia Pharmaceuticals Inc | 3.42 | -86.18% |
| APLM | Apollomics Inc - Class A | 3.42 | -86.14% |
| IMCR | Immunocore Holdings plc | 3.44 | -86.09% |
| PTHS | Channel Therapeutics Corporation | 3.44 | -86.08% |
| BMRN | Biomarin Pharmaceutical Inc | 3.45 | -86.03% |
| CUE | Cue Biopharma Inc | 3.58 | -85.53% |
| ARCT | Arcturus Therapeutics Holdings Inc | 3.62 | -85.34% |
| SLDB | Solid Biosciences Inc | 3.65 | -85.25% |
| GERN | Geron Corp | 3.66 | -85.17% |
| DTIL | Precision Biosciences Inc | 3.69 | -85.06% |
| IPSC | Century Therapeutics Inc | 3.72 | -84.96% |
| RGNX | Regenxbio Inc | 3.77 | -84.73% |
| ADMA | Adma Biologics Inc | 3.78 | -84.70% |
| BRNS | Barinthus Biotherapeutics Plc. | 3.80 | -84.63% |
| ATRA | Atara Biotherapeutics Inc | 3.80 | -84.61% |
| PHAT | Phathom Pharmaceuticals Inc | 3.82 | -84.53% |
| INCY | Incyte Corp | 3.85 | -84.43% |
| GMAB | Genmab | 3.85 | -84.40% |
| INVA | Innoviva Inc | 3.96 | -84.00% |
| TLX | Telix Pharmaceuticals Ltd | 3.97 | -83.95% |
| QTTB | Q32 Bio Inc | 4.06 | -83.57% |
| EVAX | Evaxion Biotech A/S | 4.20 | -83.01% |
| CLLS | Cellectis | 4.29 | -82.66% |
| ZLAB | Zai Lab Ltd | 4.31 | -82.55% |
| REGN | Regeneron Pharmaceuticals Inc | 4.33 | -82.48% |
| STRO | Sutro Biopharma Inc | 4.34 | -82.44% |
| ABUS | Arbutus Biopharma Corp | 4.34 | -82.42% |
| BCYC | Bicycle Therapeutics Plc | 4.43 | -82.07% |
| YMAB | Y-Mabs Therapeutics Inc | 4.57 | -81.51% |
| CHRS | Coherus Biosciences Inc | 4.67 | -81.09% |
| TRAW | Traws Pharma Inc | 4.70 | -81.00% |
| IVVD | Invivyd Inc | 4.75 | -80.78% |
| ONC | BeiGene Ltd | 4.77 | -80.71% |
| ENTA | Enanta Pharmaceuticals Inc | 4.77 | -80.70% |
| TARS | Tarsus Pharmaceuticals Inc | 4.93 | -80.07% |
| GYRE | Gyre Therapeutics Inc | 4.93 | -80.04% |
| ARVN | Arvinas Inc | 5.04 | -79.61% |
| ACHV | Achieve Life Sciences Inc | 5.09 | -79.40% |
| FDMT | 4D Molecular Therapeutics Inc | 5.17 | -79.08% |
| ELAB | PMGC Holdings Inc | 5.26 | -78.71% |
| CAI | Caris Life Sciences Inc - Class A | 5.35 | -78.35% |
| RNA | Atrium Therapeutics Inc | 5.51 | -77.70% |
| OSRH | Bellevue Life Sciences Acquisition Corp | 5.58 | -77.42% |
| HALO | Halozyme Therapeutics Inc | 5.62 | -77.26% |
| EXEL | Exelixis Inc | 5.66 | -77.10% |
| LEGN | Legend Biotech Corp | 5.68 | -77.02% |
| VYGR | Voyager Therapeutics Inc | 5.74 | -76.77% |
| KROS | Keros Therapeutics Inc | 5.92 | -76.04% |
| FENC | Fennec Pharmaceuticals Inc | 5.93 | -76.00% |
| MRVI | Maravai LifeSciences Holdings Inc - Class A | 6.02 | -75.66% |
| IOVA | Iovance Biotherapeutics Inc | 6.03 | -75.60% |
| SCPH | scPharmaceuticals Inc | 6.10 | -75.33% |
| SEER | Seer Inc - Class A | 6.13 | -75.19% |
| ASMB | Assembly Biosciences Inc | 6.37 | -74.22% |
| CPRX | Catalyst Pharmaceuticals Inc | 6.43 | -73.98% |
| DYAI | Dyadic International Inc DE | 6.46 | -73.86% |
| VCEL | Vericel Corp | 6.47 | -73.82% |
| ZVRA | Zevra Therapeutics Inc | 6.53 | -73.58% |
| IMMP | Immutep Ltd | 6.62 | -73.21% |
| ANAB | AnaptysBio Inc | 6.63 | -73.17% |
| CYCN | Cyclerion Therapeutics Inc | 6.71 | -72.85% |
| MRKR | Marker Therapeutics Inc | 6.72 | -72.81% |
| VSTM | Verastem Inc | 6.77 | -72.61% |
| ALGS | Aligos Therapeutics Inc | 6.79 | -72.52% |
| AUPH | Aurinia Pharmaceuticals Inc | 6.87 | -72.20% |
| ARQT | Arcutis Biotherapeutics Inc | 6.99 | -71.71% |
| TECH | Bio-Techne Corp | 7.04 | -71.51% |
| ZNTL | Zentalis Pharmaceuticals Inc | 7.13 | -71.15% |
| TCRX | Tscan Therapeutics Inc | 7.14 | -71.12% |
| PSTV | Plus Therapeutics Inc | 7.16 | -71.03% |
| SNDX | Syndax Pharmaceuticals Inc | 7.21 | -70.82% |
| ICU | SeaStar Medical Holding Corp | 7.32 | -70.38% |
| OBIO | Orchestra BioMed Holdings Inc | 7.36 | -70.22% |
| PTCT | PTC Therapeutics Inc | 7.39 | -70.10% |
| PYXS | Pyxis Oncology Inc | 7.57 | -69.37% |
| XTLB | X.T.L. Biopharmaceuticals Ltd | 7.58 | -69.34% |
| PRTA | Prothena Corporation plc | 7.65 | -69.04% |
| NTBL | Notable Labs Inc Ord | 7.65 | -69.04% |
| TBPH | Theravance Biopharma Inc | 7.74 | -68.68% |
| BNTX | BioNTech SE | 7.77 | -68.56% |
| FHTX | Foghorn Therapeutics Inc | 8.01 | -67.59% |
| TVTX | Travere Therapeutics Inc | 8.11 | -67.18% |
| ARTV | Artiva Biotherapeutics Inc | 8.11 | -67.18% |
| LPCN | Lipocine Inc | 8.44 | -65.85% |
| MRNA | Moderna Inc | 8.51 | -65.56% |
| XNCR | Xencor Inc | 9.05 | -63.38% |
| GOVX | Geovax Labs Inc | 9.09 | -63.22% |
| ALEC | Alector Inc | 9.16 | -62.93% |
| VRTX | Vertex Pharmaceuticals Inc | 9.26 | -62.53% |
| ALNY | Alnylam Pharmaceuticals Inc | 9.27 | -62.49% |
| SPRY | ARS Pharmaceuticals Inc | 9.29 | -62.41% |
| TGTX | TG Therapeutics Inc | 9.48 | -61.64% |
| NXTC | Nextcure Inc | 9.52 | -61.48% |
| MDGL | Madrigal Pharmaceuticals Inc | 9.68 | -60.83% |
| ACET | Adicet Bio Inc | 9.72 | -60.67% |
| SNGX | Soligenix Inc | 9.78 | -60.43% |
| URGN | UroGen Pharma Ltd | 9.78 | -60.43% |
| LENZ | LENZ Therapeutics Inc | 9.83 | -60.22% |
| MIRM | Mirum Pharmaceuticals Inc | 10.06 | -59.29% |
| HOWL | Werewolf Therapeutics Inc | 10.21 | -58.69% |
| BLRX | Bioline Rx Ltd | 10.30 | -58.32% |
| IKT | Inhibikase Therapeutics Inc | 10.39 | -57.96% |
| TNXP | Tonix Pharmaceuticals Holding Corp | 10.41 | -57.88% |
| MGTX | MeiraGTx Holdings plc | 10.61 | -57.07% |
| CORT | Corcept Therapeutics Inc | 10.82 | -56.22% |
| XOMA | XOMA Corp | 10.84 | -56.14% |
| NUVB | Nuvation Bio Inc - Class A | 11.15 | -54.88% |
| CTNM | Contineum Therapeutics Inc - Class A | 11.15 | -54.88% |
| KURA | Kura Oncology Inc | 11.19 | -54.72% |
| ATHE | Alterity Therapeutics Ltd | 11.33 | -54.15% |
| BCDA | BioCardia Inc | 11.35 | -54.07% |
| PRQR | ProQR Therapeutics N.V | 11.36 | -54.03% |
| IDYA | Ideaya Biosciences Inc | 11.59 | -53.10% |
| CCCC | C4 Therapeutics Inc | 11.61 | -53.02% |
| ARGX | Argen X SE | 11.62 | -52.98% |
| IONS | Ionis Pharmaceuticals Inc | 11.72 | -52.57% |
| PALI | Palisade Bio Inc | 11.78 | -52.33% |
| RCUS | Arcus Biosciences Inc | 11.79 | -52.29% |
| OABI | OmniAb Inc | 11.92 | -51.77% |
| LXRX | Lexicon Pharmaceuticals Inc | 11.99 | -51.48% |
| ACOG | Alpha Cognition Inc | 12.05 | -51.24% |
| XBIT | XBiotech Inc | 12.23 | -50.51% |
| MDWD | MediWound Ltd | 12.69 | -48.65% |
| CRVO | CervoMed Inc | 12.81 | -48.16% |
| SLGL | Sol-Gel Technologies Ltd | 13.01 | -47.35% |
| COYA | Coya Therapeutics Inc | 13.03 | -47.27% |
| RPRX | Royalty Pharma plc - Class A | 13.13 | -46.87% |
| SRRK | Scholar Rock Holding Corp | 13.14 | -46.83% |
| CLGN | CollPlant Biotechnologies Ltd New | 13.46 | -45.53% |
| ANL | Adlai Nortye Ltd | 13.52 | -45.27% |
| XCUR | Exicure Inc | 13.61 | -44.93% |
| EDIT | Editas Medicine Inc | 13.68 | -44.64% |
| GDTC | CytoMed Therapeutics Ltd | 14.64 | -40.76% |
| CVAC | CureVac N.V. | 14.83 | -39.99% |
| APLT | Applied Therapeutics Inc | 14.86 | -39.87% |
| CRBU | Caribou Biosciences Inc | 15.23 | -38.37% |
| ASND | Ascendis Pharma A/S | 15.38 | -37.76% |
| CANF | Can-Fite Biopharma Ltd | 15.39 | -37.72% |
| WVE | Wave Life Sciences Ltd | 15.48 | -37.36% |
| ARWR | Arrowhead Pharmaceuticals Inc | 16.61 | -32.79% |
| LGND | Ligand Pharmaceuticals Inc - Class B | 17.76 | -28.13% |
| IMNN | Imunon Inc | 17.94 | -27.41% |
| IPHA | Innate Pharma | 18.25 | -26.15% |
| AXSM | Axsome Therapeutics Inc | 18.26 | -26.11% |
| CTMX | CytomX Therapeutics Inc | 18.28 | -26.03% |
| BEAM | Beam Therapeutics Inc | 18.35 | -25.75% |
| PRLD | Prelude Therapeutics Inc | 18.82 | -23.84% |
| SEPN | Septerna Inc | 19.01 | -23.08% |
| ABCL | AbCellera Biologics Inc | 19.62 | -20.61% |
| NRXS | Neuraxis Inc | 19.67 | -20.41% |
| LGVN | Longeveron Inc - Class A | 20.01 | -19.03% |
| EQ | Equillium Inc | 20.22 | -18.18% |
| NTRB | Nutriband Inc | 20.35 | -17.65% |
| LIXT | Lixte Biotechnology Holdings Inc | 20.35 | -17.65% |
| ZYME | Zymeworks BC Inc | 20.65 | -16.44% |
| LCTX | Lineage Cell Therapeutics Inc | 20.75 | -16.03% |
| VIR | Vir Biotechnology Inc | 21.24 | -14.05% |
| ABEO | Abeona Therapeutics Inc | 21.68 | -12.27% |
| NRIX | Nurix Therapeutics Inc | 22.04 | -10.81% |
| KRYS | Krystal Biotech Inc | 22.46 | -9.12% |
| PLUR | Pluri Inc | 22.60 | -8.55% |
| BBIO | BridgeBio Pharma Inc | 22.76 | -7.90% |
| APM | Aptorum Group Ltd - Class A | 23.35 | -5.51% |
| UNCY | Unicycive Therapeutics Inc | 23.75 | -3.90% |
| VIVS | VivoSim Labs Inc | 24.05 | -2.68% |
| RXRX | Recursion Pharmaceuticals Inc - Class A | 24.06 | -2.64% |
| VRDN | Viridian Therapeutics Inc | 24.56 | -0.62% |
| AGIO | Agios Pharmaceuticals Inc | 25.34 | +2.54% |
| NBP | NovaBridge Biosciences. | 25.39 | +2.74% |
| DARE | Dare Bioscience Inc | 25.50 | +3.19% |
| RNXT | RenovoRx Inc | 25.79 | +4.36% |
| IGC | IGC Pharma Inc | 25.79 | +4.36% |
| CGEM | Cullinan Oncology Inc | 25.86 | +4.64% |
| INSM | Insmed Inc | 26.19 | +5.98% |
| CBUS | Cibus Global Ltd. Class A | 26.70 | +8.04% |
| BRTX | BioRestorative Therapies Inc | 26.77 | +8.33% |
| IRD | Ocuphire Pharma Inc | 26.80 | +8.45% |
| SLS | SELLAS Life Sciences Group Inc | 26.90 | +8.85% |
| NTLA | Intellia Therapeutics Inc | 27.23 | +10.19% |
| ABVC | ABVC BioPharma Inc | 27.42 | +10.96% |
| VTGN | VistaGen Therapeutics Inc | 27.63 | +11.81% |
| RYTM | Rhythm Pharmaceuticals Inc | 27.90 | +12.90% |
| WHWK | Whitehawk Therapeutics Inc | 30.04 | +21.56% |
| ADAG | Adagene Inc | 30.75 | +24.43% |
| IMTX | Immatics N.V | 32.50 | +31.51% |
| GLUE | Monte Rosa Therapeutics Inc | 32.74 | +32.48% |
| RANI | Rani Therapeutics Holdings Inc Class A | 33.95 | +37.38% |
| NKTR | Nektar Therapeutics | 34.15 | +38.19% |
| MESO | Mesoblast Ltd | 34.34 | +38.96% |
| SRZN | Surrozen Inc | 34.52 | +39.69% |
| MTNB | Matinas Biopharma Holdings Inc | 34.81 | +40.86% |
| OCUL | Ocular Therapeutix Inc | 35.64 | +44.22% |
| FATE | Fate Therapeutics Inc | 36.36 | +47.13% |
| HYPD | Eyenovia Inc | 36.62 | +48.18% |
| TOVX | Theriva Biologics Inc | 37.25 | +50.73% |
| XFOR | X4 Pharmaceuticals Inc | 39.03 | +57.94% |
| KRRO | Korro Bio Inc | 39.75 | +60.85% |
| CBIO | N/A | 40.77 | +64.98% |
| KTTA | Pasithea Therapeutics Corp | 42.15 | +70.56% |
| TRDA | Entrada Therapeutics Inc | 42.62 | +72.46% |
| PGEN | Precigen Inc | 43.89 | +77.60% |
| LEXX | Lexaria Bioscience Corp | 44.19 | +78.82% |
| BYSI | BeyondSpring Inc | 45.99 | +86.10% |
| ADXN | Addex Therapeutics Ltd | 47.60 | +92.61% |
| PHIO | Phio Pharmaceuticals Corp | 48.01 | +94.27% |
| VYNE | VYNE Therapeutics Inc | 48.39 | +95.81% |
| SPRB | Spruce Biosciences Inc | 49.19 | +99.05% |
| CLDI | Calidi Biotherapeutics Inc | 50.83 | +105.68% |
| IBRX | ImmunityBio Inc | 51.86 | +109.85% |
| PPBT | Purple Biotech Ltd | 51.90 | +110.01% |
| NBTX | Nanobiotix | 52.28 | +111.55% |
| SGMT | Sagimet Biosciences Inc - Class A | 52.50 | +112.44% |
| ARMP | Armata Pharmaceuticals Inc | 53.35 | +115.88% |
| KZIA | Kazia Therapeutics Ltd | 53.44 | +116.25% |
| STOK | Stoke Therapeutics Inc | 55.29 | +123.73% |
| MCRB | Seres Therapeutics Inc | 55.92 | +126.28% |
| CAMP | CAMP4 Therapeutics Corp | 57.28 | +131.78% |
| JANX | Janux Therapeutics Inc | 58.53 | +136.84% |
| ONCY | Oncolytics Biotech Inc | 58.60 | +137.13% |
| ACIU | AC Immune SA | 58.97 | +138.62% |
| PRTC | PureTech Health plc American Depositary Shares | 59.84 | +142.14% |
| GLMD | Galmed Pharmaceuticals Ltd | 61.38 | +148.38% |
| OVID | Ovid Therapeutics Inc | 62.50 | +152.91% |
| COCP | Cocrystal Pharma Inc | 62.50 | +152.91% |
| MAZE | Maze Therapeutics Inc | 65.47 | +164.93% |
| EPIX | Essa Pharma Inc | 65.79 | +166.21% |
| DMAC | DiaMedica Therapeutics Inc | 66.68 | +169.82% |
| NRXP | NRX Pharmaceuticals Inc | 70.46 | +185.12% |
| ACRS | Aclaris Therapeutics Inc | 72.11 | +191.79% |
| OMER | Omeros Corporation | 72.94 | +195.15% |
| TNGX | Tango Therapeutics Inc | 73.25 | +196.41% |
| IVA | Inventiva | 73.66 | +198.07% |
| EVMN | Evommune Inc | 73.80 | +198.63% |
| ALLR | Allarity Therapeutics Inc | 74.08 | +199.77% |
| APRE | Aprea Therapeutics Inc | 74.64 | +202.03% |
| IMA | Ikena Oncology Inc | 83.32 | +237.16% |
| RAPP | Rapport Therapeutics Inc | 84.20 | +240.72% |
| ORMP | Oramed Pharmaceuticals Inc | 86.55 | +250.23% |
| CYTK | Cytokinetics Inc | 87.83 | +255.41% |
| OGEN | Oragenics Inc | 89.28 | +261.27% |
| OCGN | Ocugen Inc | 90.22 | +265.08% |
| QNTM | FSD Pharma Inc - Class B - Class B (Sub Voting) | 91.86 | +271.71% |
| QURE | uniQure N.V. | 92.23 | +273.21% |
| CVM | Cel-Sci Corp | 92.88 | +275.84% |
| ADVM | Adverum Biotechnologies Inc | 94.37 | +281.87% |
| PTGX | Protagonist Therapeutics Inc | 95.50 | +286.44% |
| SILO | SILO Pharma Inc | 96.26 | +289.52% |
| AEON | AEON Biopharma Inc - Class A | 97.16 | +293.16% |
| MREO | Mereo Biopharma Group Plc | 97.27 | +293.60% |
| MIST | Milestone Pharmaceuticals Inc | 98.25 | +297.57% |
| HIND | ReShape Lifesciences Inc | 99.95 | +304.45% |
| UPB | Upstream Bio Inc | 102.88 | +316.31% |
| RLYB | Rallybio Corp | 107.21 | +333.83% |
| MNOV | Medicinova Inc | 107.25 | +333.99% |
| HUMA | Humacyte Inc | 115.08 | +365.67% |
| SKYE | Skye Bioscience Inc | 117.90 | +377.08% |
| ZBIO | Zenas Biopharma Inc | 119.50 | +383.56% |
| AIM | AIM ImmunoTech Inc. | 120.98 | +389.55% |
| PRME | Prime Medicine Inc | 121.34 | +391.00% |
| CAPR | Capricor Therapeutics Inc | 124.43 | +403.51% |
| KYMR | Kymera Therapeutics Inc | 125.01 | +405.85% |
| RNAC | Cartesian Therapeutics Inc | 127.79 | +417.10% |
| EYPT | EyePoint Pharmaceuticals Inc | 135.77 | +449.40% |
| OPT | Opthea Ltd | 151.40 | +512.63% |
| NAMS | NewAmsterdam Pharma Company NV | 151.95 | +514.87% |
| MOLN | Molecular Partners AG | 156.56 | +533.52% |
| DBVT | DBV Technologies | 165.40 | +569.29% |
| CRBP | Corbus Pharmaceuticals Holdings Inc | 169.88 | +587.42% |
| GRDX | Entero Therapeutics Inc | 182.31 | +637.72% |
| CRDF | Cardiff Oncology Inc | 192.74 | +679.93% |
| LSTA | Lisata Therapeutics Inc | 193.38 | +682.52% |
| GRCE | Acasti Pharma Inc | 197.75 | +700.20% |
| CRNX | Crinetics Pharmaceuticals Inc | 200.27 | +710.40% |
| SER | AgeX Therapeutics Inc | 200.74 | +712.30% |
| GTBP | GT Biopharma Inc | 204.96 | +729.37% |
| TSHA | Taysha Gene Therapies Inc | 207.70 | +740.46% |
| ASBP | Aspire Biopharma Holdings Inc | 210.28 | +750.90% |
| AZTR | Azitra Inc | 239.97 | +871.04% |
| ATYR | Atyr Pharma Inc | 241.72 | +878.12% |
| GANX | Gain Therapeutics Inc | 255.50 | +933.88% |
| CMPX | Compass Therapeutics Inc | 269.28 | +989.65% |
| RLAY | Relay Therapeutics Inc | 275.39 | +1014.37% |
| CYBN | Cybin Inc | 278.25 | +1025.94% |
| IBIO | iBio Inc | 311.32 | +1159.76% |
| STTK | Shattuck Labs Inc | 314.77 | +1173.72% |
| SLN | Silence Therapeutics Plc | 337.79 | +1266.87% |
| CDIO | Cardio Diagnostics Holdings Inc | 344.81 | +1295.28% |
| CLRB | Cellectar Biosciences Inc | 348.47 | +1310.09% |
| VRNA | Verona Pharma Plc | 350.73 | +1319.23% |
| ATNM | Actinium Pharmaceuticals Inc | 352.10 | +1324.78% |
| AUTL | Autolus Therapeutics plc | 365.22 | +1377.87% |
| ALMS | Alumis Inc | 366.45 | +1382.85% |
| ANIX | Anixa Biosciences Inc | 377.78 | +1428.69% |
| ATAI | ATAI Life Sciences N.V. | 395.29 | +1499.55% |
| OTLK | Outlook Therapeutics Inc | 396.96 | +1506.30% |
| CNTA | Centessa Pharmaceuticals plc | 409.21 | +1555.87% |
| TENX | Tenax Therapeutics Inc | 414.72 | +1578.17% |
| YDES | YD Bio Ltd | 430.93 | +1643.76% |
| CADL | Candel Therapeutics Inc | 436.42 | +1665.98% |
| NGNE | Neoleukin Therapeutics Inc | 438.73 | +1675.33% |
| JUNS | Jupiter Neurosciences Inc | 448.27 | +1713.93% |
| LXEO | Lexeo Therapeutics Inc | 478.26 | +1835.29% |
| LNAI | Lunai Bioworks Inc | 489.28 | +1879.88% |
| IMNM | Immunome Inc | 512.24 | +1972.79% |
| ABSI | Absci Corp | 532.00 | +2052.75% |
| ABOS | Acumen Pharmaceuticals Inc | 538.78 | +2080.18% |
| TVRD | Cara Therapeutics Inc | 559.61 | +2164.47% |
| IMRX | Immuneering Corp Class A | 563.62 | +2180.70% |
| CNTB | Connect Biopharma Holdings Ltd | 581.00 | +2251.03% |
| OCS | Oculis Holding AG | 590.44 | +2289.22% |
| SYRE | Spyre Therapeutics Inc | 650.22 | +2531.12% |
| TNYA | Tenaya Therapeutics Inc | 662.57 | +2581.10% |
| XENE | Xenon Pharmaceuticals Inc | 727.44 | +2843.60% |
| GRCL | Gracell Biotechnologies Inc | 732.21 | +2862.90% |
| INMB | INmune Bio Inc | 760.34 | +2976.73% |
| SNTI | Senti Biosciences Inc | 786.90 | +3084.20% |
| VRAX | Virax Biolabs Group Ltd - Class A | 793.06 | +3109.13% |
| COGT | Cogent Biosciences Inc | 861.15 | +3384.66% |
| PROK | ProKidney Corp - Class A | 876.39 | +3446.32% |
| PRAX | Praxis Precision Medicines Inc | 953.14 | +3756.90% |
| CGON | Cg Oncology Inc | 955.25 | +3765.43% |
| INBX | Inhibrx Biosciences Inc | 1009.72 | +3985.85% |
| CRSP | CRISPR Therapeutics AG | 1241.19 | +4922.49% |
| ERNA | Ernexa Therapeutics Inc | 1275.37 | +5060.80% |
| PCSA | Processa Pharmaceuticals Inc | 1320.06 | +5241.64% |
| TTNP | Titan Pharmaceuticals Inc (de) | 1459.05 | +5804.07% |
| ENTX | Entera Bio Ltd | 1547.08 | +6160.28% |
| IBO | Impact BioMedical Inc | 1573.08 | +6265.49% |
| ABVX | Abivax | 1589.40 | +6331.53% |
| INO | Inovio Pharmaceuticals Inc | 1712.37 | +6829.13% |
| TCRT | Alaunos Therapeutics Inc | 1774.63 | +7081.07% |
| ATOS | Atossa Therapeutics Inc | 1872.06 | +7475.32% |
| MBIO | Mustang Bio Inc | 2205.73 | +8825.52% |
| PULM | Pulmatrix Inc | 2459.21 | +9851.23% |
| ROIV | Roivant Sciences Ltd | 2538.35 | +10171.47% |
| CELZ | Creative Medical Technology Holdings Inc | 2618.47 | +10495.68% |
| CLDX | Celldex Therapeutics Inc | 2685.97 | +10768.82% |
| BNTC | Benitec Biopharma Inc | 2770.13 | +11109.37% |
| PLRX | Pliant Therapeutics Inc | 3071.82 | +12330.16% |
| DNTH | Dianthus Therapeutics Inc | 3126.94 | +12553.21% |
| NTHI | NeOnc Technologies Holdings Inc | 3477.63 | +13972.28% |
| KYTX | Kyverna Therapeutics Inc | 3513.34 | +14116.78% |
| CMRX | Chimerix Inc | 3613.35 | +14521.47% |
| DNLI | Denali Therapeutics Inc | 3643.65 | +14644.08% |
| SMMT | Summit Therapeutics Inc | 3891.31 | +15646.24% |
| PMN | ProMIS Neurosciences Inc | 4016.22 | +16151.69% |
| ALXO | Alx Oncology Holdings Inc | 5085.96 | +20480.41% |
| IFRX | InflaRx N.V. | 6161.81 | +24833.85% |
| GUTS | Fractyl Health Inc | 7575.74 | +30555.34% |
| ALLO | Allogene Therapeutics Inc | 7784.36 | +31399.53% |
| LPTX | Leap Therapeutics Inc | 8475.88 | +34197.76% |
| RLMD | Relmada Therapeutics Inc | 9001.90 | +36326.32% |
| RVMD | Revolution Medicines Inc | 9035.10 | +36460.66% |
| AVTX | Avalo Therapeutics Inc | 9875.25 | +39860.34% |
| LYEL | Lyell Immunopharma Inc | 10048.71 | +40562.25% |
| ALT | Altimmune Inc | 10694.01 | +43173.47% |
| PMCB | PharmaCyte Biotech Inc | 12904.41 | +52117.88% |
| GNLX | Genelux Corp | 16030.45 | +64767.45% |
| VTVT | vTv Therapeutics Inc - Class A | 17944.71 | +72513.53% |
| DSGN | Design Therapeutics Inc | 29402.82 | +118878.94% |
| TRML | Tourmaline Bio Inc | 30893.12 | +124909.47% |
| TIL | Instil Bio Inc | 54248.82 | +219418.65% |
| ETNB | 89bio Inc | 111568.68 | +451364.29% |
| EDSA | Edesa Biotech Inc | 130462.29 | +527817.57% |
| SVRA | Savara Inc | 145272.62 | +587747.79% |
| AKTX | Akari Therapeutics Plc | 478368.50 | +1935625.17% |
| NKTX | Nkarta Inc | 1.00M | +4046414.70% |